Quantitative guidelines for the prediction of ultrasound contrast agent destruction during injection.

Experiments and theory were undertaken on the destruction of ultrasound contrast agent microbubbles on needle injection, with the aim of predicting agent loss during in vivo studies. Agents were expelled through a variety of syringe and needle combinations, subjecting the microbubbles to a range of pressure drops. Imaging of the bubbles identified cases where bubbles were destroyed and the extent of destruction. Fluid-dynamic calculations determined the pressure drop for each syringe and needle combination. It was found that agent destruction occurred at a critical pressure drop that depended only on the type of microbubble. Protein-shelled microbubbles (sonicated bovine serum albumin) were virtually all destroyed above their critical pressure drop of 109 ± 7 kPa Two types of lipid-shelled microbubbles were found to have a pressure drop threshold above which more than 50% of the microbubbles were destroyed. The commercial lipid-shelled agent Definity was found to have a critical pressure drop for destruction of 230 ± 10 kPa; for a previously published lipid-shelled agent, this value was 150 ± 40 kPa. It is recommended that attention to the predictions of a simple formula could preclude unnecessary destruction of microbubble contrast agent during in vivo injections. This approach may also preclude undesirable release of drug or gene payloads in targeted microbubble therapies. Example values of appropriate injection rates for various agents and conditions are given.

Movement and dislocation of modular stent-grafts due to pulsatile flow and the pressure difference between the stent-graft and the aneurysm sac.

PURPOSE: To investigate the stability and movement of modular aortic stent-grafts subjected to oscillating forces from pulsatile blood flow, with particular reference to the thoracic aorta. METHODS: Analytical mathematical modeling was used to understand the forces on modular grafts. In a benchtop experiment, a transparent acrylic box was filled with water to mimic an aneurysm. Two stent-grafts were placed inside the box in a nested, arched configuration where one component was partly inside the other. A pump produced a pulsatile approximately 5-L/min flow of water through the stent-grafts at a mean inlet pressure of approximately 100 mmHg (approximately 13,330 Pa), with systolic and diastolic pressures of approximately 130 and approximately 80 mmHg, respectively (pulse pressure 50 mmHg). The movement of the 2 modular stent-grafts was observed. RESULTS: The curved stent-graft system oscillated transversely when there was zero mean pressure difference between the stent-graft and the aneurysm. As the mean pressure difference was increased, this transverse graft movement was damped and then disappeared. A relatively large pressure difference caused the stent-graft to inflate and become sturdier. In terms of stability, the analytical mathematical model for a 30-mm-diameter Zenith modular stent-graft curved through 90 degrees (with the ends of the graft fixed in place) showed that the modular components will separate at a pressure difference of 0 mmHg for 1 stent segment overlap (20 mm) and at an average 59 mmHg pressure difference for 2 stent overlaps, but the device would not separate at a pressure difference of 90 mmHg for 3 stent overlaps. CONCLUSION: Transverse cyclic movement of the curved stent-graft system with pulsation indicates a pressurized sac. When the pressure difference is large and there is a blood-tight seal between the aneurysm and the stent-graft, then the transverse movement of the stent-graft is minimal, but the risk for modular separation is highest. Curved thoracic endografts are subject to forces that may cause migration or separation, the latter being more likely if the seal between the graft and the sac is blood tight, if the blood pressure is high, and if the diameter of the graft is small and the sac large. Operators should plan for maximum overlap of modular components when treating large or long thoracic aneurysms.